The COVID-19 pandemic exposed vulnerabilities in society's ability to respond swiftly to a global public health threat. Recognizing the urgent need for next-generation personal protective equipment (PPE), XCMR was founded to develop breakthrough technology for respiratory protection and infection control. Our goal: commercialize innovative devices that leverage safe, continuous UVC irradiation to neutralize pathogens.
Today, XCMR's foundational research and development, alongside academic, commercial, and US Government partners, have sparked a growing ecosystem dedicated to Electromagnetic Energy for Infection Transmission Resiliency (EMITR™). This broad-based platform harnesses novel applications of UVC irradiation, combined with data and sensor fusion, to combat airborne biological threats.
While some companies use UVC to disinfect built environments, XCMR focuses on close-range protection, targeting the primary zone of transmission and infection. Our Near-field Infection Protection (NIP)™ devices provide biosafety barriers against aerosol transmission in various stationary and mobile settings, wherever people or animals interact closely.
XCMR's next generation of mobile biodefense and biosecurity solutions are poised to revolutionize protection against biological threats. By integrating the safest and most effective spectrum of UVC energy into wearable, portable, and stationary NIP devices, XCMR can significantly reduce exposure to airborne pathogens. We create a controlled, continuous, "invisible" bubble of irradiated air, maximizing infection prevention and mitigating the risks associated with antimicrobial resistance.
Moreover, XCMR's NIP technology is expected to drastically reduce environmental waste from single-use masks, lower the incidence and prevalence of respiratory diseases (e.g., flu, RSV, hMPV), and potentially serve as a universal safety device akin to seat belts for public health. This innovative approach is also far more capital and time efficient than traditional medical countermeasures like antibiotics and vaccines.
With a highly experienced, multidisciplinary team of scientific and business experts, XCMR's mission is clear: to transform biodefense and biosecurity efforts, providing robust protection for military and civilian populations alike. Our solutions ensure optimal efficacy in real-world conditions while prioritizing human safety, comfort, affordability, and accessibility for all.
